MedTrace Logo

Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy

NCT02032316 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2015-01-14

No results posted yet for this study

Summary

A prospective, single-center, single-arm, trial to demonstrate safety and device performance of the ADVA-Tec Uriprene™ Degradable Temporary Ureteral Stent. This is a first-in-man clinical study in a small human population.

Conditions

  • Unilateral Ureteral Stone
  • Renal Stone Fragments ≤ 2mm

Interventions

DEVICE

Post-Ureteroscopy ADVA-Tec Uriprene™ Degradable Temporary Ureteral Stent

Renal stent placed after uncomplicated uteroscopy

Sponsors & Collaborators

  • University of British Columbia

    collaborator OTHER

  • Adva-Tec

    lead INDUSTRY

Principal Investigators

  • Ben Chew, MD · University of British Columbia

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02032316 on ClinicalTrials.gov